Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across different risk strata: divergence of conclusions with risk difference and restricted mean survival difference
View ORCID ProfileCarolien C.H.M. Maas, View ORCID ProfileDavid M. Kent, View ORCID ProfileAvinash G. Dinmohamed, View ORCID ProfileDavid van Klaveren
doi: https://doi.org/10.1101/2024.12.19.24319347
Carolien C.H.M. Maas
1Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands
2Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands
3Predictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, USA
David M. Kent
3Predictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, USA
Avinash G. Dinmohamed
1Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands
2Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands
David van Klaveren
1Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands
3Predictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, USA
Data Availability
The trial data can be requested at NHLBI (https://biolincc.nhlbi.nih.gov/studies). Project home page: https://github.com/CHMMaas/TutorialRDvsdRMST.
Posted December 22, 2024.
Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across different risk strata: divergence of conclusions with risk difference and restricted mean survival difference
Carolien C.H.M. Maas, David M. Kent, Avinash G. Dinmohamed, David van Klaveren
medRxiv 2024.12.19.24319347; doi: https://doi.org/10.1101/2024.12.19.24319347
Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across different risk strata: divergence of conclusions with risk difference and restricted mean survival difference
Carolien C.H.M. Maas, David M. Kent, Avinash G. Dinmohamed, David van Klaveren
medRxiv 2024.12.19.24319347; doi: https://doi.org/10.1101/2024.12.19.24319347
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2946)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12753)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4587)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4362)
- Nursing (236)
- Nutrition (639)
- Oncology (2273)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (496)
- Public and Global Health (6944)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)